In Blow To Ivax, Judge Upholds Lexapro Patent

Law360, New York (July 14, 2006, 12:00 AM EDT) -- A federal judge has upheld Forest Laboratories Inc.’s patent on the blockbuster antidepressant drug Lexapro, thwarting Ivax Pharmaceuticals Corp.’s plans to market a generic.

In an opinion issued Thursday in the U.S. District Court in Delaware, Judge Joseph Farnan, Jr. rejected Ivax’s argument that the patent was anticipated, obvious and impermissibly broadened upon reissue.

“The defendants have failed to carry their ultimate burden of demonstrating invalidity by clear and convincing evidence,” Farnan wrote.

In the trial, which began in March, Ivax acknowledged that it infringed Forest...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.